SYKEHUSINNKJØP HFVADSØTED
Covid-19 vaccines
The contracting authority for this competition is the Directorate of Medical Products in cooperation with the Norwegian Institute of Public Health and the Norwegian Directorate of Health. Sykehusinnkjøp shall, on behalf of the contracting authority, procure Covid 19 vaccines.
Pharmaceuticals
No credit card · Instant access
Content at a glance
- Tender type:
- Tender
- Contracting authority:
- SYKEHUSINNKJØP HF
- Published:
- August 20, 2026
- Deadline:
- September 30, 2026
- Topic:
- Pharmaceuticals
Tender description
The contracting authority for this competition is the Directorate of Medical Products in cooperation with the Norwegian Institute of Public Health and the Norwegian Directorate of Health. Sykehusinnkjøp shall, on behalf of the contracting authority, procure Covid 19 vaccines.
Further details
With free access, documents, deadlines and submission notes are available in a structured format.
- Core requirements of the tender prioritized and prepared
- Deadlines, eligibility criteria and documents in one workflow
- Guidance for structured bid preparation
- Automatically discover matching follow-up tenders
30 days free · no credit card · cancel anytime
All procurement details
Buyer, lots, participants, locations, documents, and procedure data have already been captured. Open any area to see the complete information in your workspace.
4 data areas available
30 days free · no credit card · cancel anytime
Related tenders
10GHA065 SOLAR VACCINE FRIDGES FOR NORTH-EAST REGION
IOMPhilippinesDeadline: Sep 15GHA065_SOLAR VACCINE FRIDGES FOR 3 COMMUNITIES IN NORTH-EAST REGION OF GHANA IOM seeks qualified suppliers to provide and deliver 3 Solar vaccine refrigerators to support health operations in 3 communities in the North-East Region of Ghana. All equipment must meet the minimum technical specifications outlined in the solicitation documents. The contract will be awarded to the lowest-cost technically compliant bidder.Framework contract for RSV vaccines
European Commission, DG HERA - European Health Emergency Preparedness and Response AuthorityBrusselsBy protecting citizens through greater access to and availability of RSV vaccines, this contract can help lessen the burden on healthcare services during the winter season, when public health systems are often under greater pressure due to seasonal viruses. It can also reduce antibiotic consumption by preventing RSV infections, thereby lowering the number of patients who are prescribed antibiotics unnecessarily or as a precaution.FRAMEWORK CONTRACTFOR THE SUPPLY OF HUMAN PAPILLOMAVIRUS VACCINE (9-VALENT)
Department of ContractsFlorianaDeadline: Oct 14CT2229/2026 - FRAMEWORK CONTRACTFOR THE SUPPLY OF HUMAN PAPILLOMAVIRUS VACCINE (9-VALENT)Supply and Delivery of Human Seasonal Trivalent Influenza Vaccines
Health Service Executive (HSE)KildareThe HSE wishes to invite Tender Submissions for the supply of up to 1.2 million doses of Human Seasonal Trivalent Influenza Vaccines for the 2026/2027 season. The requirement for Human Seasonal Trivalent Influenza Vaccines can include Cell Based, Egg Based or Recombinant Vaccines. The HSE reserves the right to award a portion of the total tendered dose amount to cohort specific vaccines. The HSE will confirm its requirements after evaluation, at Contract stage. Tenderers should include provision for an additional 200,000 doses or 17 percent of the potential awarded quantity as a contingency stock.2707 Oncology
SYKEHUSINNKJØP HFVADSØDeadline: Sep 26The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF. Sykehusinnkjøp HF, division pharmaceuticals shall, on behalf of the four regional health authorities (RHF), procure medicines for the treatment of cancer. The dialogue meetings will be held in October 2026 and an invitation to the dialogue meetings is attached in this notice. We ask interested parties to register their interest in such a dialogue meeting via the communication module in Ivalua by 23 September 2026.2799a HAE
SYKEHUSINNKJØP HFVADSØDeadline: Oct 01The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF. The contracting authority shall, on behalf of the four regional health authorities in Norway enter into framework agreements for the procurement of medicines with active ingredient for heriditarian angioedema (HAE) disease. The procurement includes the following ATC groups: B06AC01 - C1 inhibitor B06AC02 - Ikatibant B06AC04 - Konestat alfa B06AC05 - Lanadelumab B06AC06 - Beroltral state B06AC07 - Garadacimab B06AC08 - Sebetral state B06AC09 - Donidalorsen See Annex 3 Requirement Specifications and The Competition Provisions for detailed information.Supply and Delivery of 6 in 1 (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Inactivated Polio Vaccine, Haemophilus Influenza Type B Conjugate) Vaccine
Health Service Executive (HSE)KildareThe HSE wishes to invite tender submissions for the supply and delivery of approximately 1,200,000 doses of 6 in 1 (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Inactivated Polio Vaccine, Haemophilus Influenza Type B Conjugate) Vaccine fully compatible with the current primary immunisation schedule in Ireland, to be delivered over approximately 5 years contract duration (approximately 240,000 doses per annum). The drawdown may vary by 20 percent depending on the cohort requirement. The HSE reserves the right to extend the contract duration by up to two years where actual demand is less than forecasted demand.Supply and Delivery of Enhanced (adjuvanted) Inactivated Influenza Vaccines for Older People
Health Service Executive (HSE)KildareThe HSE wishes to invite Tender submissions for the supply of up to 650,000 doses of Enhanced (adjuvanted) Inactivated Influenza Vaccines for older people for the 2026/2027 season. The drawdown may vary by up to 20 percent depending on the cohort requirements.2799m Ivakaftor
SYKEHUSINNKJØP HFVADSØDeadline: Sep 24On behalf of the four regional health authorities, Sykehusinnkjøp HF, division pharmaceuticals, is considering to procure the active ingredient ivacaftor. Sykehusinnkjøp would like to invite inetessenter to dialogue meetings to update us in the market. The meetings will be held via Teams on the 8th and/or the 9th of June 2018. By 3 September 2026, interested parties 2026.Vi to register their interest in such a dialogue meeting via the communication module in Ivalua.2799k ATC group A16AX08
SYKEHUSINNKJØP HFVADSØDeadline: Sep 24On behalf of the four regional health authorities, Sykehusinnkjøp HF, division pharmaceuticals, is considering to procure the active ingredient teduglutide. Sykehusinnkjøp would like to invite inetessenter to dialogue meetings to update us in the market. The meetings will be held via Teams 23 September 2026.Vi ask interested parties to register their interest in such a dialogue meeting via the communication module in Ivalua by 11 September 2026.
Frequently asked questions about this tender
- How can I apply for this tender?
- Create a free account on Auftrag One. You will then see all documents, deadlines and submission notes in a structured workflow.
- What is the submission deadline?
- The submission deadline is 30. September 2026.
- Who is the contracting authority?
- The contracting authority is SYKEHUSINNKJØP HF.
- Which documents are needed to get started?
- Typically you need the service description, proof of eligibility, deadline notes and possibly form sheets. On Auftrag One these items are displayed in prioritized order.